Combining Serotonin Reuptake Inhibitors and Bupropion in Partial Responders to Antidepressant Monotherapy
Abstract
BACKGROUND: Many patients with affective illness show partial or otherwise unsatisfactory responses to standard treatments, encouraging trials of combinations of pharmacologically dissimilar antidepressants. METHOD: Records of consecutive outpatients with affective disorders only partially responsive to treatment with a serotonin reuptake inhibitor (SRI) or bupropion, alone, were reviewed for changes in specific symptoms and risks of adverse events when an SRI and bupropion were combined. RESULTS: Greater symptomatic improvement was found in 19 (70%) of 27 subjects during a mean +/- SD of 11 +/- 14 months of combined daily use of bupropion (243 +/- 99 mg) with an SRI (31 +/- 16 mg fluoxetine-equivalents) than with either agent alone. Adverse effect risks were similar to those associated with each monotherapy, with a > 10% incidence of sexual dysfunction (N = 11, 41%), insomnia (N = 6, 22%), anergy (N = 4, 15%), and tremor (N = 3, 11%) during combined therapy; there were no seizures. CONCLUSION: With conservative dosing and close monitoring, combinations of SRIs with bupropion in this uncontrolled clinical series appeared to be safe and often more effective than monotherapy.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Although both DA and non-DA agents can effectively treat mood disorders, DA agents generally have superior effects on symptoms of anhedonia compared with non-DA agents.
“Particularly relevant in the present context are previous reports [290,296,297] that although both DA and non-DA agents can be used to effectively treat mood disorders, DA agents generally have superior effects on symptoms of anhedonia, specifically when compared with non-DA agents [19,298-300].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [298]
Cited by
Sorted by citations
Reconsidering anhedonia in depression: Lessons from translational neuroscience
Treadway, M. T., & Zald, D. H. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.006 · Cited by 1,579 · see citing works
Effects of SSRIs on Sexual Function
Rosen, R. C., Lane, R. M., & Menza, M. A. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00013 · Cited by 649 · see citing works
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 549 · see citing works
D, M. F. M., Rush, A. J., Trivedi, M. H., Nierenberg, A. A., Thase, M. E., Sackeïm, H. A., Quitkin, F. M., Wisniewski, S. R., Lavori, P. W., Rosenbaum, J. F., et al. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00107-7 · Cited by 520 · see citing works
Stahl, S. M., Pradko, J., Haight, B. R., Modell, J. G., Rockett, C. B., & Learned-Coughlin, S. (2004) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v06n0403 · Cited by 495 · see citing works
Hesse, L. M., Venkatakrishnan, K., Court, M. H., Moltke, L. L., Duan, S., Shader, R. I., & Greenblatt, D. J. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0026-895x(24)12046-9 · Cited by 397 · see citing works
Nutt, D., Demyttenaere, K., Janka, Z., Aarre, T., Bourin, M., Canonico, P. L., Carrasco, J. L., & Stahl, S. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106069938 · Cited by 366 · see citing works
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320 · see citing works
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299 · see citing works
The many faces of fatigue in major depressive disorder
Demyttenaere, K., De Fruyt, J., & Stahl, S. M. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004729 · Cited by 288 · see citing works
15 Years of Clinical Experience With Bupropion HCl
D, M. F. M., Rush, A. J., Thase, M. E., Clayton, A. H., Stahl, S. M., Pradko, J. F., & Johnston, J. A. (2005) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v07n0305 · Cited by 258 · see citing works
Anhedonia and Substance Dependence: Clinical Correlates and Treatment Options
Hatzigiakoumis, D. S., Martinotti, G., Giannantonio, M. D., & Janiri, L. (2011) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00010 · Cited by 238 · see citing works
Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression
Yoshimura, R., Hori, H., Ikenouchi, A., Umene‐Nakano, W., Ueda, N., & Nakamura, J. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.03.020 · Cited by 227 · see citing works
Depression and sexual dysfunction
Baldwin, D. S. (2001) · British Medical Bulletin · doi:10.1093/bmb/57.1.81 · Cited by 217 · see citing works
Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction
Montgomery, S. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00313-5 · Cited by 205 · see citing works
Stahl, S. M., Zhang, L., Damatarca, C., & Grady, M. M. (2003) · PubMed · Cited by 202 · see citing works
Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity?
Clayton, A. H. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.4.457 · Cited by 187 · see citing works
Cao, B., Zhu, J., Zuckerman, H., Rosenblat, J. D., Brietzke, E., Pan, Z., Subramanieapillai, M., Park, C., Lee, Y., & McIntyre, R. S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.01.002 · Cited by 175 · see citing works
Choices in Antipsychotic Therapy in Schizophrenia
Frankenburg, F. R. (1999) · Harvard Review of Psychiatry · doi:10.3109/10673229909000336 · Cited by 169 · see citing works
Dopaminergic-based pharmacotherapies for depression
Papakostas, G. I. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.12.002 · Cited by 168 · see citing works
Li, S. X.-M., Perry, K. W., & Wong, D. T. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00160-5 · Cited by 156 · see citing works
Sexual side-effects of antidepressant and antipsychotic drugs
Baldwin, D. S., & Mayers, A. (2003) · Advances in Psychiatric Treatment · doi:10.1192/apt.9.3.202 · Cited by 154 · see citing works
D, M. F. M., & Rush, A. J. (2006) · Psychotherapy and Psychosomatics · doi:10.1159/000091771 · Cited by 151 · see citing works
Rapaport, M. H., Gharabawi, G. M., Canuso, C. M., Mahmoud, R. A., Keller, M. B., Bossie, C. A., Turkoz, I., Lasser, R. A., Loescher, A., Bouhours, P., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301113 · Cited by 148 · see citing works
Self-citationAssessing the effects of bupropion SR on mood dimensions of depression
Tomarken, A. J., Dichter, G. S., Freid, C., Addington, S., & Shelton, R. C. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00306-3 · Cited by 139 · see citing works
Augmentation and combination strategies in treatment-resistant depression.
D, M. F. M. (2001) · PubMed · Cited by 141 · see citing works
Use of Bupropion in Combination with Serotonin Reuptake Inhibitors
Zisook, S., Rush, A. J., Haight, B. R., Clines, D. C., & Rockett, C. B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.027 · Cited by 140 · see citing works
Can Recovery From Depression Be Achieved?
Shelton, R. C., & Tomarken, A. J. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.11.1469 · Cited by 105 · see citing works
Preclinical and Clinical Pharmacology of DOV 216,303, a “Triple” Reuptake Inhibitor
Skolnick, P., Krieter, P. A., Tizzano, J. P., Basile, A. S., Popik, P., Czobor, P., & LIPPA, A. S. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00123.x · Cited by 105 · see citing works
Gerson, S. C., Belin, T. R., Kaufman, A., Mintz, J., & Jarvik, L. (1999) · Harvard Review of Psychiatry · doi:10.1093/hrp/7.1.1 · Cited by 99 · see citing works
Therapeutic Potential of Ursolic Acid in Cancer and Diabetic Neuropathy Diseases
Alam, M., Ali, S., Ahmed, S., Elasbali, A. M., Adnan, M., Islam, A., Hassan, M. I., & Yadav, D. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212162 · Cited by 91 · see citing works
Pharmacologic approaches to treatment resistant depression: Evidences and personal experience
Tundo, A., de Filippis, R., & Proietti, L. (2015) · World Journal of Psychiatry · doi:10.5498/wjp.v5.i3.330 · Cited by 91 · see citing works
Guiard, B. P., Mansari, M. E., & Blier, P. (2009) · Current Drug Targets · doi:10.2174/138945009789735156 · Cited by 94 · see citing works
Segraves, R. T., Kavoussi, R. J., Hughes, A. R., Batey, S. R., Johnston, J. A., Donahue, R. M. J., & Ascher, J. A. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200004000-00002 · Cited by 90 · see citing works
Lam, R. W. M., Hossie, H., Solomons, K., & Yatham, L. N. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0308 · Cited by 88 · see citing works
Strategies for the treatment of antidepressant-related sexual dysfunction.
Zajecka, J. (2001) · PubMed · Cited by 86 · see citing works
DeBattista, C., Solvason, H. B., Poirier, J., Kendrick, E., & Schatzberg, A. F. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200302000-00005 · Cited by 83 · see citing works
Mischoulon, D., Nierenberg, A. A., Kizilbash, L., Rosenbaum, J. F., & D, M. F. M. (2000) · The Canadian Journal of Psychiatry · doi:10.1177/070674370004500509 · Cited by 81 · see citing works
TREAD: TReatment with Exercise Augmentation for Depression: study rationale and design
Trivedi, M. H., Greer, T. L., Grannemann, B. D., Church, T. S., Galper, D. I., Sunderajan, P., Wisniewski, S. R., Chambliss, H., JORDAN, A. N., Finley, C. E., et al. (2006) · Clinical Trials · doi:10.1191/1740774506cn151oa · Cited by 79 · see citing works
Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines
Taylor, R. W., Marwood, L., Oprea, E., DeAngel, V., Mather, S., Valentini, B., Zahn, R., Young, A. H., & Cleare, A. J. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa033 · Cited by 76 · see citing works
Investigational drugs in recent clinical trials for treatment-resistant depression
Garay, R. P., Zarate, C. A., Charpeaud, T., Citrome, L., Correll, C. U., Hameg, A., & Llorca, P. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1283217 · Cited by 74 · see citing works
Thase, M. E. (2004) · CNS Spectrums · doi:10.1017/s1092852900002236 · Cited by 67 · see citing works
Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases
Ramos-Hryb, A. B., Pazini, F. L., Kaster, M. P., & Rodrigues, A. L. S. (2017) · CNS Drugs · doi:10.1007/s40263-017-0474-4 · Cited by 66 · see citing works
The combination of duloxetine and bupropion for treatment-resistant major depressive disorder
Papakostas, G. I., Worthington, J. J., Iosifescu, D. V., Kinrys, G., Burns, A. M., Fisher, L. B., Homberger, C. H., Mischoulon, D., & D, M. F. M. (2006) · Depression and Anxiety · doi:10.1002/da.20181 · Cited by 61 · see citing works
Triple Reuptake Inhibitors: The Next Generation of Antidepressants
Marks, D., Pae, C., & Patkar, A. A. (2008) · Current Neuropharmacology · doi:10.2174/157015908787386078 · Cited by 57 · see citing works
Progression of Subcortical Ischemic Disease From Vascular Depression to Vascular Dementia
Steffens, D. C., Taylor, W. D., & Krishnan, K. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1751 · Cited by 54 · see citing works
Combination/augmentation strategies for improving the treatment of depression
Moret, C. (2005) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a798 · Cited by 50 · see citing works
Psychopharmacologic Treatments for Nonparaphilic Compulsive Sexual Behaviors
Kafka, M. P. (2000) · CNS Spectrums · doi:10.1017/s1092852900012669 · Cited by 50 · see citing works
Mood and metabolism: Anhedonia as a clinical target in Type 2 diabetes
Carter, J., & Swardfager, W. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.04.002 · Cited by 49 · see citing works
Pramipexole Augmentation of a Selective Serotonin Reuptake Inhibitor in the Treatment of Depression
DeBattista, C., Solvason, H. B., Breen, J. A. H., & Schatzberg, A. F. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200004000-00029 · Cited by 48 · see citing works
Combined antidepressants: clinical experience
Rojo, E., Ros, S., Agüera, L., de la Gándara, J., & de Pedro, J. M. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00677.x · Cited by 48 · see citing works
Augmentation and combination strategies for depression
DeBattista, C. (2006) · Journal of Psychopharmacology · doi:10.1177/1359786806064310 · Cited by 47 · see citing works
A Critical Overview of the Pharmacologic Management of Treatment-Resistant Depression
Nierenberg, A. A., Katz, J., & D, M. F. M. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2007.01.001 · Cited by 47 · see citing works
Topiramate Abuse in a Bipolar Patient With an Eating Disorder
Colom, F., Vieta, E., Benabarre, A., Martínez‐Arán, A., Reinares, M., Corbella, B., & Gastó, C. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0612c · Cited by 47 · see citing works
Soskin, D. P., Carl, J. R., Alpert, J. E., & D, M. F. M. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2012.00318.x · Cited by 44 · see citing works
PHARMACOLOGIC TREATMENT FOR CHILDREN AND ADOLESCENTS WITH ANXIETY DISORDERS
Birmaher, B. B., Yelovich, A. K., & Renaud, J. (1998) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70069-9 · Cited by 45 · see citing works
Leuchter, A. F., Lesser, I. M., Trivedi, M. H., Rush, A. J., Morris, D. W., Warden, D., D, M. F. M., Wisniewski, S. R., Luther, J. F., Perales, M. L., et al. (2008) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000336754.19566.65 · Cited by 45 · see citing works
Medical management of obesity associated with mental disorders.
Malhotra, S., & McElroy, S. L. (2002) · PubMed · Cited by 44 · see citing works
Tamiz, A. P., Zhang, J., Flippen-Anderson, J. L., Zhang, M., Johnson, K. M., Deschaux, O., Tella, S. R., & Kozikowski, A. P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9905561 · Cited by 44 · see citing works
Barowsky, J., & Schwartz, T. L. (2006) · PubMed Central · Cited by 40 · see citing works
Switching to Bupropion in Fluoxetine-Resistant Major Depressive Disorder
D, M. F. M., Papakostas, G., Petersen, T., Mahal, Y., Quitkin, F., Stewart, J., & McGrath, P. (2003) · Annals of Clinical Psychiatry · doi:10.1023/a:1023224525400 · Cited by 40 · see citing works
Devadoss, T., Pandey, D. K., Mahesh, R., & Yadav, S. K. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70263-2 · Cited by 38 · see citing works
Antidepressant drug development: Focus on triple monoamine reuptake inhibition
Lane, R. M. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114553252 · Cited by 40 · see citing works
Reboxetine adjunct for partial or nonresponders to antidepressant treatment
Rubio, G., San, L., Lopez-Munoz, F. J., & Álamo, C. (2003) · Journal of Affective Disorders · doi:10.1016/j.jad.2003.08.001 · Cited by 38 · see citing works
Nelson, J. C., S, L. P. M., & Leon, A. C. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.030 · Cited by 36 · see citing works
Pharmacological Profile of the “Triple” Monoamine Neurotransmitter Uptake Inhibitor, DOV 102,677
Popik, P., Krawczyk, M., Gołembiowska, K., Nowak, G., Janowsky, A. J., Skolnick, P., LIPPA, A. S., & Basile, A. S. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9012-5 · Cited by 35 · see citing works
Depression Treatment in Patients With General Medical Conditions: Results From the CO-MED Trial
Morris, D. W., Budhwar, N., Husain, M. M., Wisniewski, S. R., Kurian, B. T., Luther, J., Kerber, K. A., Rush, A. J., & Trivedi, M. H. (2012) · The Annals of Family Medicine · doi:10.1370/afm.1316 · Cited by 32 · see citing works
McGahuey, C. A., Delgado, P. L., & Gelenberg, A. J. (1999) · Psychiatric Annals · doi:10.3928/0048-5713-19990101-10 · Cited by 32 · see citing works
Do venlafaxine XR and paroxetine equally influence negative and positive affect?
Dichter, G. S., Tomarken, A. J., Freid, C. M., Addington, S., & Shelton, R. C. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.10.007 · Cited by 30 · see citing works
What to do when SSRIs fail: eight strategies for optimizing treatment of panic disorder.
Zamorski, M. A., & Albucher, R. C. (2002) · PubMed · Cited by 30 · see citing works
ANTIDEPRESSANT AUGMENTATION AND COMBINATIONS
Dording, C. M. (2000) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70195-7 · Cited by 29 · see citing works
Treatment of Depression in Children and Adolescents
Bostic, J. Q., Rubin, D. H., Prince, J. B., & Schlozman, S. C. (2005) · Journal of Psychiatric Practice · doi:10.1097/00131746-200505000-00002 · Cited by 28 · see citing works
Triple Reuptake Inhibitors: A Premise and Promise
Marks, D. M., Pae, C., & Patkar, A. A. (2008) · Psychiatry Investigation · doi:10.4306/pi.2008.5.3.142 · Cited by 27 · see citing works
Venlafaxine and Bupropion Combination Therapy in a Case of Treatment-Resistant Depression
Fatemi, S. H., Emamian, E. S., & Kist, D. A. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18249 · Cited by 27 · see citing works
Nurnberg, H. G. (2001) · Journal of Psychiatric Practice · doi:10.1097/00131746-200103000-00003 · Cited by 26 · see citing works
Internet-Observed Suicide Attempts
Janson, M. P., Alessandrini, E. S., Strunjas, S. S., Shahab, H., El‐Mallakh, R. S., & Lippmann, S. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0612f · Cited by 24 · see citing works
Learned, S. M., Graff, O. X., Roychowdhury, S. M., Moate, R., Krishnan, K., Archer, G. E., Modell, J. G., Alexander, R., Zamuner, S., Lavergne, A., et al. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111424931 · Cited by 23 · see citing works
Therapieresistenz auf Antidepressiva
Møller, H. J. (2004) · Der Nervenarzt · doi:10.1007/s00115-004-1728-1 · Cited by 23 · see citing works
Woo, Y. S., Bahk, W., Jeong, J., Lee, S., Sung, H., Pae, C., Koo, B., & Kim, W. K. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12042 · Cited by 21 · see citing works
Augmentation of standard depression therapy
Marangell, L. B. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)80071-5 · Cited by 21 · see citing works
Sildenafil in the Treatment of Sexual Dysfunction Induced by Selective Serotonin Reuptake Inhibitors
Nurnberg, H. G., Hensley, P. L., & Lauriello, J. (2000) · CNS Drugs · doi:10.2165/00023210-200013050-00003 · Cited by 21 · see citing works
Yoshimura, R., Umene‐Nakano, W., Ueda, N., Ikenouchi, A., Hori, H., & Nakamura, J. (2008) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.979 · Cited by 20 · see citing works
Clinical Pharmacology and Therapeutics of Antidepressants
Ciraulo, D. A., Tsirulnik-Barts, L., Shader, R. I., & Greenblatt, D. J. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-792-5_2 · Cited by 20 · see citing works
Skolnick, P. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-852-6_9 · Cited by 19 · see citing works
Using semantic analysis of texts for the identification of drugs with similar therapeutic effects
Tutubalina, E. V., Miftahutdinov, Z., Ирекович, Н. Р., Madzhidov, T., Nikolenko, S., Alimova, I., & Tropsha, A. (2017) · Russian Chemical Bulletin · doi:10.1007/s11172-017-2000-8 · Cited by 20 · see citing works
Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression
Axford, L. C., Boot, J. R., Hotten, T. M., Keenan, M., Martin, F. M., Milutinovic, S., Moore, N. A., O‘Neill, M. F., Pullar, I. A., Tupper, D. E., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00660-7 · Cited by 19 · see citing works
Bae, K., Kim, S., Kim, J. M., Shin, I., Yoon, J., Jung, S.-W., Lee, M., Yim, H. W., & Jun, T. (2011) · Psychiatry Investigation · doi:10.4306/pi.2011.8.3.234 · Cited by 18 · see citing works
Nierenberg, A. A., & Alpert, J. E. (2000) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70194-5 · Cited by 18 · see citing works
Anhedonia: Current and future treatments
Serretti, A. (2025) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.70088 · Cited by 17 · see citing works
Does Dual Antidepressant Therapy as Initial Treatment Hasten and Increase Remission from Depression?
Stewart, J. W., McGrath, P. J., Deliyannides, R. A., & Quitkin, F. M. (2009) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000361276.88339.44 · Cited by 17 · see citing works
Clinical Pharmacology and Therapeuticsof Antidepressants
Ciraulo, D. A., Shader, R. I., & Greenblatt, D. J. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-435-7_2 · Cited by 16 · see citing works
Goldberg, J. F. (2000) · Emergency Medicine Clinics of North America · doi:10.1016/s0733-8627(05)70119-x · Cited by 16 · see citing works
Treatment Options for the Patient Who Does Not Respond Well to Initial Antidepressant Therapy
Preskorn, S. (2009) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000351880.30013.2a · Cited by 15 · see citing works
The Many Uses of Bupropion and Bupropion Sustained Release (SR) in Adults
Berigan, T. R. (2002) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v04n0110a · Cited by 15 · see citing works
ASHP Therapeutic Position Statement on the Recognition and Treatment of Depression in Older Adults
Semla, T. P., & Watanabe, M. D. (1998) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/55.23.2514 · Cited by 15 · see citing works
Gabapentin for the Treatment of Patients With Somatization Disorder
García‐Campayo, J., & Sanz-Carrillo, C. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0612a · Cited by 15 · see citing works
Strategies for Augmentation of SSRI Treatment: A Survey of an Academic Psychopharmacology Practice
Mischoulon, D., D, M. F. M., & Rosenbaum, J. F. (1999) · Harvard Review of Psychiatry · doi:10.3109/10673229909017210 · Cited by 15 · see citing works
Zheng, M., Appel, L., Luo, F. R., Lane, R. M., Burt, D. A., Risinger, R. C., Antoni, G., Cahir, M., Keswani, S. C., Hayes, W., et al. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3688-x · Cited by 12 · see citing works
"I See Dead People": Overcoming Psychic Numbness
Brendel, D. H., Bodkin, J. A., Hauptman, B., & Ornstein, A. (2002) · Harvard Review of Psychiatry · doi:10.1080/10673220216216 · Cited by 12 · see citing works
Self-citationSeguı́, J., Lopez-Munoz, F. J., Álamo, C., Camarasa, X., García, P. G., & Pardo, A. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109102641 · Cited by 12 · see citing works
- Authors
- Bodkin, J. A., Lasser, R. A., Wines, J. D., Gardner, D. M., & Baldessarini, R. J.
- Affiliations
- Harvard University (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 1997-04-15
- Volume
- 58
- Issue
- 4
- Pages
- 137-145
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1982954842
- Cited by
- 159
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 4 · 2017: 4 · 2016: 2 · 2015: 2 · 2014: 3 · 2013: 1 · 2012: 6
- FWCI
- 7.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k05mh047370-25)
- National Institute of Mental Health (P01MH031154, MH-31154, MH47370)
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- serotonin reuptake inhibitors, bupropion, antidepressant combination therapy, antidepressant monotherapy, mood disorders, adverse drug reactions, sexual dysfunction, insomnia, anergia, tremor, seizure risk
- MeSH terms
- Adult, Aged, Ambulatory Care, Anxiety Disorders, Depressive Disorder, Drug Administration Schedule, Drug Therapy, Combination, Epilepsy, Female, Fluoxetine, Humans, Male, Middle Aged, 1-Naphthylamine, Panic Disorder, Bupropion, Fluvoxamine, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Dysthymic Disorder, Sertraline
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
